Diagnosis and treatment of intrahepatic cholangiocarcinoma
10.3760/cma.j.cn115396-20200521-00164
- VernacularTitle:肝内胆管细胞癌的诊治进展
- Author:
Fei CAO
1
;
Peng LIU
;
Peng GONG
Author Information
1. 深圳大学总医院普外科 518052
- From:
International Journal of Surgery
2020;47(6):411-415
- CountryChina
- Language:Chinese
-
Abstract:
Intrahepatic cholangiocarcinoma (ICC) is a liver malignant tumor, and its incidence is second only to hepatocellular carcinoma, accounting for 5%-30% of patients with primary liver cancer. Usually it is characterized by insidious attack, high degree of malignancy, postoperative recurrence, and being asymptomatic at the early stage, most patients have developed into the advanced stage when the diagnosis is confirmed. Thus, early laboratory examinations and imaging judgments are particularly important, providing opportunities for early radical resection of patients. The purpose of this paper is to review and update the medical literature to provide new ideas for diagnosis and treatment of ICC.